The main activities of Allopharm
Allopharm is engaged in the search for, development and commercialization of new medicinal substances, the prototypes of which are based on the active components of insect immune systems, with antiviral, antitumor and antibacterial action. Some of the preparations developed by the company, obtained through complete chemical synthesis or biosynthesis in insect cultures, have already found application in medicine and dermatocosmetology.
Studying insect immune systems as the basis of scientific discoveries
The creation of technologies for the introduction of newly acquired knowledge into modern medicine
Cooperation with Russian and foreign institutions in the field of developing new methods of treatment and disease prevention
Scientific developments
The most promising developments of Allopharm are based on fundamental research by its researchers in the field of insect biopharmacology and immunology
Our team
Shevchenko Olga
CEO
Biologist, financier
Chernysh Sergey
Founder
Doctor of Biological Sciences
Head of the Laboratory of Insect Biopharmacology and Immunology of SPBU
Head of the Laboratory of Insect Biopharmacology and Immunology of SPBU
Chernysh Natalia
Founder
Biologist